Grant Review Committee 2022-2023
Andrew Aplin, PhD
Associate Director, Basic Research
Program Leader, Cancer Cell Biology & Signaling, NCI-designated
Sidney Kimmel Cancer Center
Professor, Department of Cancer Biology
Thomas Jefferson University
Boris Bastian, MD, PhD
Professor, Dermatology and Pathology
Gerson and Barbara Bass Bakar Distinguished Professor, Cancer
Research
University of California, San Francisco
Emily Bernstein, PhD
Co-leader of the Cancer Mechanisms Research Program
The Tisch Cancer Institute
Professor, Oncological Sciences
Professor, Dermatology
Ichan School of Medicine at Mount Sinai
Nina Bhardwaj, MD, PhD
Professor of Medicine and Urology
Director of Immunotherapy
Medical Director of the Vaccine and Cell Therapy Laboratory
Co-Director of the Cancer Immunology Program, The Tisch Cancer
Institute
Icahn School of Medicine at Mount Sinai
Marcus Bosenberg, MD, PhD
Professor of Dermatology, Pathology, and Immunobiology
Co-Leader, Genetics, Genomics and Epigenetics, Yale Cancer Center
Director, Yale Center for Immuno-Oncology
Director, Yale SPORE in Skin Cancer
Yale School of Medicine
David Fisher, MD, PhD
Chief, Dermatology Service
Director, Melanoma Program, MGH Cancer Center
Director, Cutaneous Biology Research Center
Massachusetts General Hospital
Jeffrey Gershenwald, MD — Co-Chair
Medical Director, Melanoma and Skin Center
Professor, Department of Surgical Oncology
The University of Texas MD Anderson
Cancer Center
Ana Carrizosa Anderson, PhD — Chair
Associate Professor, Neurology
Harvard Medical School
Associate Scientist, Neurology
Brigham and Women’s Hospital
Keith Flaherty, MD
Professor, Medicine
Harvard Medical School
Co-Leader, Developmental Therapeutics
Dana-Farber / Harvard Cancer Center
Director, Henri and Belinda Termeer Center for Targeted Therapies,
Cancer Center
Director, Clinical Research, Cancer Center
Massachusetts General Hospital
Thomas Gajewski, MD, PhD
AbbVie Foundation Professor of Pathology
Professor, Ben May Department of Cancer Research
Professor, Medicine
University of Chicago
Richard Carvajal, MD
Associate Professor of Medicine at CUIMC
Director, Experimental Therapeutics
Director, Melanoma Service
Columbia University Irving Medical Center
Co-Leader, Precision Oncology and Systems Biology Program
Herbert Irving Comprehensive Cancer Center
Paul Chapman, MD
Attending Physician, Melanoma and Immunotherapeutics Service
Professor of Medicine, Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center
Tanja de Gruijl, PhD
Professor, Medical Oncology Laboratory
Professor, Amsterdam Infection and Immunity – Cancer Immunology
Professor, Cancer Center Amsterdam – Cancer Biology and
Immunology, Imaging and Biomarkers
Vrije Universiteit, Amsterdam
Stephanie Dougan, PhD
Principal Investigator, Cancer Immunology and Virology
Associate Professor of Immunology, Harvard Medical School
Dana-Farber Cancer Institute
J. William Harbour, MD
Professor, Ophthalmology, Biochemistry and Molecular Biology
Mark J. Daily Chair, Ophthalmology,
Vice Chairman, Translational Research
Director, Ocular Oncology
Eye Cancer Site Disease Group Leader
Associate Director, Basic Research, Sylvester Comprehensive
Cancer Center
Bascom Palmer Eye Institute, University of Miami
Eva M. Hernando-Monge, PhD
Professor, Department of Pathology
New York University Langone Health
Thomas Hornyak, MD, PhD
Chief, Dermatology
Associate Chief of Staff, Research & Development
VA Maryland Health Care System
Associate Professor, Dermatology and Biochemistry and
Molecular Biology
University of Maryland School of Medicine
Roger Lo, MD, PhD
Director, Melanoma Clinic in Dermatology
Director, Dermatology STAR Residency Program
Professor, Medicine
Associate Chief and Professor, Dermatology
Professor, Molecular & Medical Pharmacology
University of California, Los Angeles, David Geffen School of Medicine
David Lombard, MD, PhD
Professor
Department of Pathology & Laboratory Medicine
Co-Leader, Cancer Epigenetics Program
Sylvester Comprehensive Cancer Center
Miller School of Medicine
Michal Lotem, MD
Head, Center for Melanoma and Cancer Immunotherapy, Dept of
Oncology
Hadassah Hebrew University Medical Center
Glenn Merlino, PhD
Senior Investigator, Laboratory of Cancer Biology and Genetics
Head, Cancer Modeling Section
Scientific Director for Basic Research, CCR
National Cancer Institute
Poulikos Poulikakos, PhD
Associate Professor, Department of Oncological Sciences
Icahn School of Medicine at Mount Sinai
Precision Immunology Institute
The Tisch Cancer Institute
Antoni Ribas, MD, PhD
Professor of Medicine, Surgery, Molecular and Medical
Pharmacology
Director, Tumor Immunology Program, Jonsson Comprehensive
Cancer Center
Director, Parker Institute for Cancer Immunotherapy Center
at UCLA
University of California Los Angeles
Caroline Robert, MD, PhD
Head, Dermatology Unit
Co-Director, Melanoma Research Unit
Professor, Dermatology
Institute Gustave Roussy
Jonathan Simons, MD
Chief Science Officer
Medical Director
The Marcus Foundation
Craig Slingluff, MD
Joseph Helms Farrow Professor, Surgery
Vice Chair, Research, Department of Surgery
Director, UVA Cancer Center Human Immune Therapy Center
Co-Chair, Melanoma Committee of ECOG
The University of Virginia
Marisol Soengas, PhD
Leader, Melanoma Group
Dean for Academic Affairs
Professor, Spanish National Cancer Research Center
David Solit, MD
Geoffrey Beene Chair
Director, Marie-Josée & Henry R. Kravis Center for
Molecular Oncology
Memorial Sloan Kettering Cancer Center
Susan Swetter, MD
Professor, Dermatology
Director, Pigmented Lesion & Melanoma Program
Physician Leader, Cancer Care Program in Cutaneous
Oncology
Stanford University Medical Center & Cancer Institute
Jennifer Wargo, MD, MMSc
Professor, Genomic Medicine
Professor, Surgical Oncology
The University of Texas MD Anderson Cancer Center
Jeffrey S. Weber, MD, PhD
Deputy Director, Perlmutter Cancer Center
Co-Director, Melanoma Research Program
Laura and Isaac Perlmutter Professor of Oncology,
Department of Medicine
NYU Grossman School of Medicine
Xu Wu, PhD
Principal Investigator, Cutaneous Biology Research Center,
Massachusetts General Hospital
Associate Professor, Dermatology, Harvard Medical School
Affiliate Faculty, Harvard Stem Cell Institute
Kai Wucherpfennig, MD, PhD
Chair, Cancer Immunology and Virology
Director, Center for Cancer Immunotherapy Research
Dana-Farber Cancer Institute
Professor, Neurology, Brigham and Women’s Hospital and
Harvard Medical School
Associate Member, Broad Institute of MIT and Harvard
Iwei Yeh, MD, PhD
Associate Professor, Dermatology and Pathology
University of California, San Francisco